Dollars for Docs

How Industry Dollars Reach Your Doctors

SYNAGIS
drug

SYNAGIS

Prevents serious lung infections caused by respiratory syncytial virus (RSV) in babies and children who have a high risk of infection.
Cash
$0

payments related to this drug

Doctor
6,197

doctors receiving payments

Company
3

companies making payments related to this drug

Drug
0.08%

of payments for this drug were also associated with another product

Companies Making Payments Related to this Drug

Aggregate totals are shown, including payments to doctors and teaching hospitals. To purchase bulk data, please visit the ProPublica Data Store.

Company Payment
MEDIMMUNE, LLC $880K
ABBVIE, INC. $234K
ASTRAZENECA PHARMACEUTICALS LP $3,295

Top Doctors Receiving Payments Related to this Drug

Totals listed account for all payments from August 2013 to December 2016.

Doctor Location Money Paid
Wojtczak
Henry Wojtczak

SAN DIEGO, CA

$108K
SANCHEZ
PABLO SANCHEZ

COLUMBUS, OH

$64,904
RAMILO
OCTAVIO RAMILO

COLUMBUS, OH

$56,594
WYBLE
LANCE WYBLE

TAMPA, FL

$53,974
CHECCHIA
PAUL CHECCHIA

SAINT LOUIS, MO

$47,269
GOODMAN
GARY GOODMAN

ORANGE, CA

$38,637
FERGIE
JAIME FERGIE

CORPUS CHRISTI, TX

$34,051
MEJIAS
MARIA MEJIAS

COLUMBUS, OH

$30,281
COOPER
DAVID COOPER

CINCINNATI, OH

$30,038
FORBES
MICHAEL FORBES

AKRON, OH

$29,675

Top Teaching Hospitals Receiving Payments Related to this Drug

Note: We have made some effort to normalize the data and eliminate duplicates, but data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].